Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer. [PDF]
Djusberg E +8 more
europepmc +1 more source
Frequency of complex-to-manage, difficult-to-manage and treatment-refractory psoriatic arthritis: applying the 2025 GRAPPA and EULAR definitions in a real-world longitudinal PsA cohort. [PDF]
Koc GH +14 more
europepmc +1 more source
Revealing Hidden Dynamics of Hydrogel-Based Desalination with <sup>23</sup>Na Nuclear Magnetic Resonance. [PDF]
Zou H +5 more
europepmc +1 more source
Assessing flares in patients with psoriatic arthritis using questionnaires. [PDF]
Chronis NJ +3 more
europepmc +1 more source
Circulatory microRNA signature distinguishing rheumatoid arthritis and psoriatic arthritis. [PDF]
Tynan Ó +5 more
europepmc +1 more source
Incorporating Lower Urinary Tract Symptoms to Predict the Risk of Positive Prostate Magnetic Resonance Imaging. [PDF]
Paulino Pereira LJ +5 more
europepmc +1 more source
Pro-Inflammatory Synergy Between IL-17, IL-1 and Hyperuricemia in Psoriatic Arthritis: Clinical Implications of a Pilot Study. [PDF]
Suiu LI +5 more
europepmc +1 more source
Correction: Biochemical failure after radical prostatectomy with PSA ≤ 1 ng/mL: prediction of PSMA-positive metastatic disease. [PDF]
Santo G +5 more
europepmc +1 more source
Cardiovascular Risk in Psoriatic Arthritis: Mechanisms, Risk Assessment, and Long-Term Management Implications. [PDF]
Totolici S +3 more
europepmc +1 more source
Diagnosis of Prostate Cancer: A Comparative Evaluation of Biological Techniques. [PDF]
Tshoni UA, Mbonane TP, Rathebe PC.
europepmc +1 more source

